Gian Luca Grazi
Gian Luca Grazi
IRCCS Regina Elena National Cancer Institute
Verified email at ifo.gov.it
TitleCited byYear
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
V Mazzaferro, JM Llovet, R Miceli, S Bhoori, M Schiavo, L Mariani, ...
The lancet oncology 10 (1), 35-43, 2009
12362009
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma
L Gramantieri, M Ferracin, F Fornari, A Veronese, S Sabbioni, CG Liu, ...
Cancer research 67 (13), 6092-6099, 2007
8662007
MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma
F Fornari, L Gramantieri, M Ferracin, A Veronese, S Sabbioni, GA Calin, ...
Oncogene 27 (43), 5651, 2008
6272008
MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells
F Fornari, L Gramantieri, C Giovannini, A Veronese, M Ferracin, ...
Cancer research 69 (14), 5761-5767, 2009
4002009
Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence
G Ercolani, GL Grazi, M Ravaioli, M Del Gaudio, A Gardini, M Cescon, ...
Annals of surgery 237 (4), 536, 2003
3742003
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells
F Fornari, M Milazzo, P Chieco, M Negrini, GA Calin, GL Grazi, D Pollutri, ...
Cancer research 70 (12), 5184-5193, 2010
3662010
Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value
GL Grazi, G Ercolani, F Pierangeli, M Del Gaudio, M Cescon, A Cavallari, ...
Annals of surgery 234 (1), 71, 2001
3242001
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality
L Gramantieri, F Fornari, M Ferracin, A Veronese, S Sabbioni, GA Calin, ...
Clinical Cancer Research 15 (16), 5073-5081, 2009
3222009
Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience)
F Trevisani, S De Notariis, G Rapaccini, F Farinati, L Benvegnų, M Zoli, ...
The American journal of gastroenterology 97 (3), 734, 2002
2962002
Liver transplantation for hepatocellular carcinoma: results of down‐staging in patients initially outside the Milan selection criteria
M Ravaioli, GL Grazi, F Piscaglia, F Trevisani, M Cescon, G Ercolani, ...
American Journal of Transplantation 8 (12), 2547-2557, 2008
2932008
Evolution of hepatitis B virus polymerase gene mutations in hepatitis B e antigen–negative patients receiving lamivudine therapy
ASF Lok, M Hussain, C Cursano, M Margotti, A Gramenzi, G Luca Grazi, ...
Hepatology 32 (5), 1145-1153, 2000
2682000
Impact of model for end‐stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis
A Cucchetti, G Ercolani, M Vivarelli, M Cescon, M Ravaioli, G La Barba, ...
Liver Transplantation 12 (6), 966-971, 2006
2502006
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
2452018
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
2052018
Is portal hypertension a contraindication to hepatic resection?
A Cucchetti, G Ercolani, M Vivarelli, M Cescon, M Ravaioli, G Ramacciato, ...
Annals of surgery 250 (6), 922-928, 2009
1952009
Liver resection without blood transfusion
G Gozzetti, A Mazziotti, GL Grazi, E Jovine, A Gallucci, S Gruttadauria, ...
British Journal of Surgery 82 (8), 1105-1110, 1995
1801995
Trends in perioperative outcome after hepatic resection: analysis of 1500 consecutive unselected cases over 20 years
M Cescon, G Vetrone, GL Grazi, G Ramacciato, G Ercolani, M Ravaioli, ...
Annals of surgery 249 (6), 995-1002, 2009
1792009
Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patient
F Trevisani, PE D'Intino, P Caraceni, M Pizzo, GF Stefanini, A Mazziotti, ...
Cancer 75 (9), 2220-2232, 1995
1741995
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
1692018
Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence
M Vivarelli, A Cucchetti, G La Barba, M Ravaioli, M Del Gaudio, A Lauro, ...
Annals of surgery 248 (5), 857-862, 2008
1612008
The system can't perform the operation now. Try again later.
Articles 1–20